IRIS
SANTINI, DANIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 19.571
NA - Nord America 4.824
EU - Europa 1.969
SA - Sud America 1.336
AF - Africa 134
OC - Oceania 71
AN - Antartide 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 27.909
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 13.325
US - Stati Uniti d'America 4.532
HK - Hong Kong 2.674
CN - Cina 2.527
BR - Brasile 1.025
GB - Regno Unito 768
VN - Vietnam 533
IT - Italia 346
DE - Germania 241
IN - India 168
CA - Canada 163
AR - Argentina 151
MX - Messico 93
NL - Olanda 82
FI - Finlandia 75
ID - Indonesia 74
ZA - Sudafrica 74
AU - Australia 65
JP - Giappone 61
UA - Ucraina 60
PL - Polonia 57
EC - Ecuador 47
TR - Turchia 45
ES - Italia 42
FR - Francia 40
CZ - Repubblica Ceca 33
SE - Svezia 33
PY - Paraguay 29
RU - Federazione Russa 29
CO - Colombia 26
BD - Bangladesh 23
CL - Cile 20
PE - Perù 20
CH - Svizzera 18
BE - Belgio 17
EE - Estonia 17
LT - Lituania 17
KR - Corea 15
EG - Egitto 12
SA - Arabia Saudita 12
UZ - Uzbekistan 12
AZ - Azerbaigian 10
MA - Marocco 10
TW - Taiwan 9
AT - Austria 8
IL - Israele 8
SI - Slovenia 8
VE - Venezuela 8
PH - Filippine 7
PK - Pakistan 7
PT - Portogallo 7
RO - Romania 7
UY - Uruguay 7
AE - Emirati Arabi Uniti 6
DO - Repubblica Dominicana 6
GR - Grecia 6
HU - Ungheria 6
IQ - Iraq 6
SK - Slovacchia (Repubblica Slovacca) 6
TN - Tunisia 6
AL - Albania 5
BA - Bosnia-Erzegovina 5
GT - Guatemala 5
KZ - Kazakistan 5
MD - Moldavia 5
TH - Thailandia 5
AM - Armenia 4
BY - Bielorussia 4
DM - Dominica 4
IE - Irlanda 4
LU - Lussemburgo 4
BG - Bulgaria 3
CY - Cipro 3
HN - Honduras 3
HR - Croazia 3
KW - Kuwait 3
LA - Repubblica Popolare Democratica del Laos 3
LV - Lettonia 3
NG - Nigeria 3
NP - Nepal 3
NZ - Nuova Zelanda 3
OM - Oman 3
RS - Serbia 3
SY - Repubblica araba siriana 3
AQ - Antartide 2
BF - Burkina Faso 2
BO - Bolivia 2
BZ - Belize 2
CU - Cuba 2
DK - Danimarca 2
DZ - Algeria 2
ET - Etiopia 2
GA - Gabon 2
IR - Iran 2
JM - Giamaica 2
KG - Kirghizistan 2
KH - Cambogia 2
ME - Montenegro 2
MK - Macedonia 2
NI - Nicaragua 2
Totale 27.860
Salva come PNG Salva come JPEG
Città #
Hong Kong 2.656
Singapore 1.758
Hefei 1.389
Ashburn 1.110
Boardman 799
London 672
Shanghai 478
Dallas 445
Beijing 333
Ho Chi Minh City 195
Los Angeles 170
San Francisco 164
Council Bluffs 135
Hanoi 111
São Paulo 109
Pune 102
Seattle 102
Munich 95
Toronto 94
Santa Clara 84
New York 72
Washington 66
Rome 62
Warsaw 51
Tokyo 49
Mexico City 45
Amsterdam 44
Turku 40
Rio de Janeiro 39
Brooklyn 38
Helsinki 35
Johannesburg 35
Montreal 35
Melbourne 33
Chicago 32
Brno 29
Haiphong 28
Boston 27
Stockholm 27
Thái Bình 25
Chennai 24
Belo Horizonte 22
Da Nang 21
Biên Hòa 20
Buenos Aires 20
Milan 20
Naples 20
Secaucus 19
Phoenix 17
Canberra 16
Sydney 16
West Jordan 16
Guayaquil 15
Charlotte 14
Lima 14
Quito 14
Ankara 13
Asunción 13
Manchester 13
Paris 13
Atlanta 12
Brasília 12
Campinas 12
Curitiba 12
Hanover 12
Hasselt 12
Ninh Bình 12
Ribeirão Preto 12
St Louis 12
Tashkent 12
Oklahoma City 11
San Jose 11
Guangzhou 10
Haikou 10
Porto Alegre 10
Viamão 10
Goiânia 9
Jakarta 9
Riyadh 9
Sorocaba 9
The Dalles 9
Denver 8
Guarulhos 8
Ha Long 8
Hortolândia 8
Hyderabad 8
Hải Dương 8
Joinville 8
Maceió 8
Mumbai 8
New Delhi 8
Poplar 8
Santo André 8
Baku 7
Bauru 7
Bogotá 7
Bắc Giang 7
Cairo 7
Camaçari 7
Caxias do Sul 7
Totale 12.525
Salva come PNG Salva come JPEG
Nome #
A new dose-intense epoetin alfa regimen effective in anemic cancer patients receiving chemotherapy: An open-label, non randomized, pilot study 228
Alkaline phosphatase (alp) levels in multiple myeloma and solid cancers with bone lesions: Is there any difference? 227
A hitherto unreported high incidence of zoledronic acid-induced acute phase reaction in patients with cancer treatment-induced bone loss 218
Expression pattern of receptor activator of NFκB (RANK) in a series of primary solid tumors and related bone metastases 216
Bisphosphonates as anticancer agents in early breast cancer: preclinical and clinical evidence 210
ANGIOGENESIS AND ONCOGENES IN COLON CANCER 207
Biological Effects of Cyclin-Dependent Kinase Inhibitors Ribociclib, Palbociclib and Abemaciclib on Breast Cancer Bone Microenvironment 206
COX-2 expression in ampullary carcinoma: correlation with angiogenesis process and clinicopathological variables 206
Designing a broad-spectrum integrative approach for cancer prevention and treatment 206
A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable 204
Early impairment of food intake in patients newly diagnosed with cancer 203
A new bioinformatic pipeline allows the design of small, targeted gene panels for efficient TMB estimation 202
Repeated courses of radiation treatment in an HER2-positive breast cancer patient with diffuse brain metastases: A case report 200
S-Adenosylmethionine (AdoMet) supplementation for treatment of chemotherapy-induced liver injury 199
A key opinion leader interview with Prof D Santini: insight into cancer research. 196
Cyclooxygenase-2 overexpression is associated with a poor outcome in resected ampullary cancer patients 195
In Situ Identification of CD44+/CD24− cancer cells in primary human breast carcinomas 194
COX-2 expression in DCIS: correlation with VEGF, HER-2/neu, prognostic molecular markers and clinicopathological features 194
Premetastatic niche: ready for new therapeutic interventions? 193
Bone metastases in breast cancer: higher prevalence of osteosclerotic lesions 193
COX-2 expression in lobular in situ neoplasia of the breast: correlation with histopathological grading system according to the Tavassoli classification 193
A Novel Prognostic Tool in Western and Eastern Biliary Tract Cancer Patients Treated in First-line Setting: the ECSIPOT Index 193
A prospective analysis of CT density measurements of bone metastases after treatment with zoledronic acid 192
A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation 191
Bevacizumab in association with de Gramont 5-fluorouracil/folinic acid in patients with oxaliplatin-, irinotecan-, and cetuximab-refractory colorectal cancer: a single-center phase 2 trial 189
A phase II study of induction chemotherapy followed by concurrent chemoradiotherapy in elderly patients with locally advanced non-small-cell lung cancer 189
Enoxiparin effects depend on body-weight and current doses my be inadequate in obese patients 186
Prevention of radiotherapy-induced emesis 184
COX-2 expression of ampullary carcinoma: correlation with different histotypes and clinicopathological parameters 183
Alternative dosing schedules for sunitinib as a treatment of patients with metastatic renal cell carcinoma 183
Zoledronic acid-related angiogenesis modifications and survival in advanced breast cancer patients 182
Bisphosphonates: new antiangiogenic molecules in cancer treatment? 182
Complications of therapy in cancer patients: Case 3. Toxic epidermal necrolysis induced by oral phenobarbital and whole-brain radiotherapy in a breast cancer patient 179
Zoledronic acid induces significant and long-lasting modifications of circulating angiogenic factors in cancer patients 178
Gemcitabine-induced atrial fibrillation: A hitherto unreported manifestation of drug toxicity 174
Bisphosphonate effects in cancer and inflammatory diseases: in vitro and in vivo modulation of cytokine activities 173
NOD2/CARD15 polymorphisms impair innate immunity and increase susceptibility to gastric cancer in an Italian population 173
Body mass index and impaired fasting blood glucose as predictive factor of time to progression (TTP) in cetuximab-based colorectal cancer treatment 171
Docetaxel induced pericardial effusion 165
Longitudinal evaluation of vitamin D plasma levels during anthracycline- and docetaxel-based adjuvant chemotherapy in early-stage breast cancer patients 156
Angiogenesis modifications related with cetuximab plus irinotecan as anticancer treatment in advanced colorectal cancer patients 141
A giant sarcoma of the parotid gland: A case report and review of the literature 119
Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality? 119
'Internal bracing' surgery in the management of solid tumor metastases of the thoracic and lumbar spine 114
'All action no talk': the role of HER2/neu in adjuvant therapy choice for gastric cancer 114
Early magnesium reduction in advanced colorectal cancer patients treated with cetuximab plus irinotecan as predictive factor of efficacy and outcome 109
Bilateral irreversible hearing loss associated with the combination of carboplatin and paclitaxel chemotherapy: a unusual side effect 109
Prospective observational multicentric case-control study about 'fatigue' in patients with history of breast cancer 108
Colorectal carcinomas and PTEN/MMAC1 gene mutations 105
A prospective analysis of CT density measurements of bone metastases after treatment with zoledronic acid 105
Anestesia e malattie non comuni 103
'Old' and 'new' drugs for the treatment of cancer pain 102
Pancreatitis after percutaneous ethanol injection into HCC: a minireview of the literature 100
Carcinoma of the Ampulla of Vater morphological and immunophenotypical classification predicts overall survival 99
"Triple positive" early breast cancer: an observational multicenter retrospective analysis of outcome 99
A Phase II Trial of Fixed-Dose Rate Gemcitabine plus Capecitabine in Metastatic/Advanced Biliary Tract Cancer Patients 98
Biological effects of cabozantinib on bone microenvironment 97
A phase II study of weekly cisplatin, 6S-stereoisomer leucovorin and fluorouracil as first-line chemotherapy for elderly patients with advanced gastric cancer 96
Atypical case of metastatic undifferentiated prostate carcinoma in a 36 years old man: clinical report and literature review 95
Continuous infusion of oxaliplatin plus chronomodulated capecitabine in 5-fluorouracil- and irinotecan-resistant advanced colorectal cancer patients 95
Body Mass Index as a Risk Factor for Toxicities in Patients with Advanced Soft-Tissue Sarcoma Treated with Trabectedin 95
Changes in bone resorption and vascular endothelial growth factor after a single zoledronic acid infusion in cancer patients with bone metastases from solid tumours 94
Serum VEGF levels as predictive marker of bisphosphonate-related osteonecrosis of the jaw 93
Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment 93
Abstract P5-04-13: Antibody-based therapy targeting integrin a5 is an effective strategy to treat experimental breast cancer bone metastasis 93
An increase of CA 19.9 as the first clinical sign of ileocecal valve metastasis from breast cancer 92
Idiosyncratic reaction after oxaliplatin infusion 92
Cetuximab and irinotecan as third-line therapy in advanced colorectal cancer patients: a single centre phase II trial 92
Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions 92
Body Mass Index and Impaired Fasting Blood Glucose as Predictive Factors of Efficacy in Cetuximab-Based Colorectal Cancer Treatment 92
Biological effects of cabozantinib on osteosarcoma-bone microenvironment model 92
Changes in bone turnover markers in patients without bone metastases receiving immune checkpoint inhibitors: An exploratory analysis 91
In vivo effects of zoledronic acid on peripheral gamma delta T lymphocytes in early breast cancer patients 91
[Treatment of stage-I seminoma. Critical review] 91
Antitumor effect of cabozantinib in bone metastatic models of renal cell carcinoma 91
Different Levels of Alkaline Phospatase (ALP) in Multiple Myeloma (MM) and SOLID Tumors with BONE Lesions 91
Atypical chronic head and neck pain: don't forget Eagle's syndrome 90
Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant setting. 89
Liver cirrhosis after prolonged therapy with IFN-alpha plus interleukin-2 in a metastatic renal cancer long-term survivor 89
Apoptotic index or a combination of Bax/Bcl-2 expression correlate with survival after resection of pancreatic adenocarcinoma 89
Circulating VEGF reduction, response and outcome in advanced colorectal cancer patients treated with cetuximab plus irinotecan 88
Cox-2 Expression in Different Histotypes of Ampullary Carcinoma 87
Bone health and body composition in prostate cancer: Meet-URO and AIOM consensus about prevention and management strategies 86
Long non-coding RNA HSAT II as a new biomarker for the identification of high risk intraductal papillary mucinous neoplasms (IPMNs). 86
Antagonistic effects of chloroquine on autophagy occurrence potentiate the anticancer effects of everolimus on renal cancer cells. 86
Complete pathological response after FOLFIRINOX for locally advanced pancreatic cancer. The beginning of a new era? Case report and review of the literature 85
A phase II study of carboplatin and paclitaxel as first line chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC) 81
Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in gastric cancer of intestinal and diffuse histotypes 81
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting 80
A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study 80
A phase I trial of fixed dose rate gemcitabine plus capecitabine in metastatic cancer patients 79
LIVER TOXICITY IN COLORECTAL CANCER PATIENTS TREATED WITH FIRST LINE FOLFIRI-CONTAINING REGIMEN: A SINGLE INSTITUTION EXPERIENCE 77
Fatal thrombocytopenia and thrombocytopathia: An unusual onset of non small cell lung cancer 77
Early magnesium modifications as a surrogate marker of efficacy of cetuximab-based anticancer treatment in KRAS wild-type advanced colorectal cancer patients 71
Classic Kaposi Sarcoma: to treat or not to treat? 70
Pamidronate induces modifications of circulating angiogenetic factors in cancer patients 68
Deep Learning Algorithm Trained with COVID-19 Pneumonia Also Identifies Immune Checkpoint Inhibitor Therapy-Related Pneumonitis 66
Fever after zoledronic acid administration is due to increase in TNF-alpha and IL-6 66
Another side of the association between body mass index (BMI) and clinical outcomes of cancer patients receiving programmed cell death protein-1 (PD-1)/Programmed cell death-ligand 1 (PD-L1) checkpoint inhibitors: A multicentre analysis of immune-related adverse events 64
Weekly oxaliplatin, 5-fluorouracil and folinic acid (OXALF) as first-line chemotherapy for elderly patients with advanced gastric cancer: results of a phase II trial 61
Totale 13.211
Salva come PNG Salva come JPEG
Categoria #
all - tutte 289.601
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 289.601
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.008 0 4 5 8 73 10 15 4 42 20 23 804
2022/2023203 18 7 3 13 16 7 18 20 9 3 80 9
2023/20242.295 52 281 95 171 237 1.039 17 154 23 59 75 92
2024/202518.553 334 274 922 147 171 510 314 63 1.954 1.573 5.751 6.540
2025/20265.985 1.870 776 1.374 1.965 0 0 0 0 0 0 0 0
Totale 28.044